Weiss Multi-Strategy Advisers’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,500
Closed -$303K 641
2022
Q1
$303K Sell
12,500
-17,339
-58% -$420K 0.01% 604
2021
Q4
$696K Sell
29,839
-38,364
-56% -$772K 0.02% 520
2021
Q3
$1.13M Buy
68,203
+793
+1% +$15.3K 0.02% 489
2021
Q2
$1.64M Sell
67,410
-32,590
-33% -$736K 0.04% 430
2021
Q1
$2.58M Sell
100,000
-31,734
-24% -$1.4M 0.06% 370
2020
Q4
$7.04M Buy
131,734
+435
+0.3% +$21.6K 0.15% 209
2020
Q3
$5.42M Buy
131,299
+34,299
+35% +$1.48M 0.15% 202
2020
Q2
$4.7M Buy
97,000
+1,614
+2% +$77.5K 0.14% 220
2020
Q1
$4.03M Buy
95,386
+386
+0.4% +$15.9K 0.16% 182
2019
Q4
$4.06M Buy
95,000
+8,000
+9% +$348K 0.09% 339
2019
Q3
$3.13M Sell
87,000
-25,000
-22% -$758K 0.09% 332
2019
Q2
$2.99M Hold
112,000
0.11% 247
2019
Q1
$3.01M Buy
112,000
+2,000
+2% +$46.7K 0.1% 280
2018
Q4
$1.78M Sell
110,000
-30,000
-21% -$583K 0.09% 238
2018
Q3
$2.91M Buy
140,000
+10,000
+8% +$157K 0.12% 281
2018
Q2
$1.99M Buy
130,000
+50,000
+63% +$892K 0.07% 347
2018
Q1
$1.8M Buy
80,000
+42,500
+113% +$1.18M 0.08% 343
2017
Q4
$1.13M Buy
37,500
+12,500
+50% +$400K 0.04% 428
2017
Q3
$942K Hold
25,000
0.04% 381
2017
Q2
$697K Hold
25,000
0.04% 406
2017
Q1
$860K Buy
+25,000
New +$882K 0.04% 403
2016
Q4
Sell
-17,500
Closed -$557K 404
2016
Q3
$557K Sell
17,500
-725
-4% -$24.6K 0.04% 336
2016
Q2
$592K Sell
18,225
-6,775
-27% -$227K 0.05% 304
2016
Q1
$699K Sell
25,000
-15,500
-38% -$338K 0.04% 363
2015
Q4
$1.44M Hold
40,500
0.12% 205
2015
Q3
$1.34M Sell
40,500
-49,500
-55% -$2.06M 0.1% 229
2015
Q2
$3.77M Sell
90,000
-6,000
-6% -$232K 0.18% 172
2015
Q1
$3.13M Sell
96,000
-14,000
-13% -$481K 0.15% 182
2014
Q4
$3.49M Hold
110,000
0.18% 156
2014
Q3
$2.72M Sell
110,000
-5,000
-4% -$117K 0.1% 268
2014
Q2
$2.6M Buy
115,000
+30,000
+35% +$626K 0.09% 302
2014
Q1
$2.07M Sell
85,000
-2,410
-3% -$61K 0.06% 347
2013
Q4
$2.18M Buy
87,410
+22,412
+34% +$529K 0.06% 328
2013
Q3
$1.78M Sell
64,998
-2
-0% -$42 0.05% 355
2013
Q2
$1.18M Buy
+65,000
New +$895K 0.04% 368

Other funds holding ACAD